2YGN
WIF domain of human Wnt inhibitory factor 1 in complex with 1,2- dipalmitoylphosphatidylcholine
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE BM14 |
Synchrotron site | ESRF |
Beamline | BM14 |
Temperature [K] | 100 |
Detector technology | CCD |
Detector | MARRESEARCH |
Spacegroup name | C 2 2 2 |
Unit cell lengths | 49.912, 134.138, 60.378 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 27.529 - 1.850 |
R-factor | 0.205 |
Rwork | 0.204 |
R-free | 0.22390 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2d3j |
RMSD bond length | 0.015 |
RMSD bond angle | 2.224 |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Phasing software | PHASER |
Refinement software | PHENIX ((PHENIX.REFINE: 1.7_650)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 30.000 | 1.930 |
High resolution limit [Å] | 1.850 | 1.850 |
Rmerge | 0.100 | 0.700 |
Number of reflections | 17655 | |
<I/σ(I)> | 16.3 | 1.4 |
Completeness [%] | 98.8 | 91.3 |
Redundancy | 5.3 | 3.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 6.5 | PEG 8000 30 % W/V, 200 MM SODIUM ACETATE, 100 MM SODIUM CACODYLATE PH 6.5 . |